Translational Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX, USA.
Science. 2013 Aug 16;341(6147):792-6. doi: 10.1126/science.1240342.
Proteinases and the innate immune receptor Toll-like receptor 4 (TLR4) are essential for expression of allergic inflammation and diseases such as asthma. A mechanism that links these inflammatory mediators is essential for explaining the fundamental basis of allergic disease but has been elusive. Here, we demonstrate that TLR4 is activated by airway proteinase activity to initiate both allergic airway disease and antifungal immunity. These outcomes were induced by proteinase cleavage of the clotting protein fibrinogen, yielding fibrinogen cleavage products that acted as TLR4 ligands on airway epithelial cells and macrophages. Thus, allergic airway inflammation represents an antifungal defensive strategy that is driven by fibrinogen cleavage and TLR4 activation. These findings clarify the molecular basis of allergic disease and suggest new therapeutic strategies.
蛋白酶和先天免疫受体 Toll 样受体 4(TLR4)对于过敏炎症和哮喘等疾病的表达至关重要。将这些炎症介质联系起来的机制对于解释过敏疾病的基本基础至关重要,但一直难以捉摸。在这里,我们证明 TLR4 被气道蛋白酶活性激活,从而引发过敏性气道疾病和抗真菌免疫。这些结果是通过凝血蛋白纤维蛋白原的蛋白酶切割诱导的,产生的纤维蛋白原裂解产物在气道上皮细胞和巨噬细胞上作为 TLR4 配体起作用。因此,过敏性气道炎症代表了一种由纤维蛋白原裂解和 TLR4 激活驱动的抗真菌防御策略。这些发现阐明了过敏疾病的分子基础,并提出了新的治疗策略。